Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Audioboom chairman snaps up shares

(Sharecast News) - Audioboom revealed on Monday that chairman Michael Tobin had acquired 10,620 ordinary shares in the AIM-listed podcasting business. Tobin, who took over as chairman in August 2018, purchased the shares on Friday at an average price of 215.0p each, for a total value of 22,833.00.

Following the transaction, Tobin holds a beneficial interest in 850,000 ordinary Audioboom shares, representing approximately 5.2% of the company's issued share capital.

As of 1245 BST, Audioboom shares were up 1.18% at 215.0p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Creo Medical Group (CREO) Director name: Crofton,Kevin Amount purchased: 2,916,666 @ 24.00p Value: £699,999.82

Digital 9 Infrastructure Npv (DGI9) Director name: Burrow ,Robert Amount purchased: 1,000,000 @ 17.96p Value: £179,550.01

Digital 9 Infrastructure Npv (DGI9) Director name: Burrow ,Robert Amount purchased: 350,000 @ 18.06p Value: £63,215.98

Creo Medical Group (CREO) Director name: Rees,Richard John Amount purchased: 208,333 @ 24.00p Value: £49,999.92

Lindsell Train Inv Trust (LTI) Director name: Lindsell,Michael Amount purchased: 34 @ 73,300.00p Value: £24,922.00

Audioboom Group (BOOM) Director name: Tobin,Michael Amount purchased: 10,620 @ 215.00p Value: £22,833.00

Cohort (CHRT) Director name: Thomis,Andrew Stephen Amount purchased: 365 @ 492.00p Value: £1,795.80

Cohort (CHRT) Director name: Walther,Simon Amount purchased: 365 @ 492.00p Value: £1,795.80

Top Director Sells

Share this article

Related Sharecast Articles

Director dealings: Bioventix chairman raises stake
(Sharecast News) - Bioventix revealed on Monday that chairman Ian Nicholson had acquired 1,000 ordinary shares in the AIM-listed biotechnology firm.
Director dealings: Bioventix chairman raises stake
(Sharecast News) - Bioventix revealed on Monday that chairman Ian Nicholson had acquired 1,000 ordinary shares in the AIM-listed biotechnology firm.
Director dealings: Frontier Developments founder lowers stake
(Sharecast News) - Frontier Developments revealed on Friday that founder and president David Braben had disposed of 13,000 ordinary shares in the AIM-listed video games developer.
Director dealings: Altitude director snaps up shares
(Sharecast News) - Altitude Group revealed on Thursday that non-executive director Bob Wigley had acquired 200,000 ordinary shares in the AIM-listed technology and services provider.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.